# FDA Inspection 1155044 - Octapharma Plasma Inc - September 21, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/bf68b346-5d5d-41c1-90f0-786ac8ec6b19
Source feed: FDA_Inspections

> FDA Inspection 1155044 for Octapharma Plasma Inc on September 21, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1155044
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-09-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1155044 - 2021-09-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/49c7437f-f771-4a3d-92f1-5581d6c93b3d)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/93f9346e-9b2a-4a14-803b-79283fb0beee

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d